NEW YORK / Apr 09, 2025 / Business Wire / Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025.
Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows:
Live Call: 1.855.761.5600
Conference ID: 7768132
Webcast
The call will be archived and available on Oscar’s investor relations website (ir.hioscar.com) following May 7, 2025 for a period of 90 days.
About Oscar Health
Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.8 million members, as of February 1, 2025.
| Last Trade: | US$20.67 |
| Daily Change: | -0.77 -3.59 |
| Daily Volume: | 10,730,810 |
| Market Cap: | US$4.380B |
May 07, 2025 February 04, 2025 November 07, 2024 August 22, 2024 August 07, 2024 | |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
